Search Results - "Magnetta, Defne A."

Association Between High Sensitivity Troponin I and NTproBNP With Rejection and Graft Loss in Pediatric Heart Transplant Recipients by Magnetta, Defne A., Jackson, Laurel, Zeevi, Adriana, Turnquist, Heth R., Miller, Susan A., West, Shawn C., Murtagh, Gillian, Feingold, Brian

“…ABSTRACT Background Troponin I is a blood biomarker of cardiac injury and levels measured using a high‐sensitivity assay after pediatric heart transplantation…”
Get full text

Impact of the 2016 revision of US Pediatric Heart Allocation Policy on waitlist characteristics and outcomes by Magnetta, Defne A., Godown, Justin, West, Shawn, Zinn, Matthew, Rose‐Felker, Kirsten, Miller, Susan, Feingold, Brian

“…US Pediatric Heart Allocation Policy was recently revised, deprioritizing candidates with cardiomyopathy while maintaining status 1A eligibility for congenital…”
Get full text

Interventions on residual lesions in patients with heterotaxy syndrome following orthotropic heart transplantation: A single‐center experience by Pedamallu, Havisha, O'Halloran, Conor P., Morrison, Adam, Monge, Michael C., Magnetta, Defne A., Tannous, Paul

“…Background Heterotaxy syndrome (HS) is a defect in lateralization which often results in complex intra and extracardiac abnormalities. Orthotropic heart…”
Get full text

Donor‐specific antibodies after heart transplantation for Fontan‐associated protein‐losing enteropathy by Magnetta, Defne A., Hoch, Virginia L., Pinelli, David, Monge, Michael, Pahl, Elfriede, Thrush, Philip T.

“…Background Despite ubiquitous exposure to sensitizing events, most Fontan PLE patients have low panel reactive antibodies (PRA). To assess whether they are at…”
Get full text

Biventricular Assist Device Support for Intractable Arrhythmias From Histiocytoid Cardiomyopathy by Magnetta, Defne A., Reichhold, Allison, Thrush, Philip T., Monge, Michael, Webster, Gregory, Joong, Anna

“…Histiocytoid cardiomyopathy (HICMP) is a rare mitochondrial cardiomyopathy associated with recurrent life-threatening arrhythmias and variable degrees of…”
Get full text

Histopathology, mRNA expression profile, and donor‐derived cell‐free DNA for assessment of rejection in pediatric heart transplantation by O'Halloran, Conor P., Tannous, Paul, Arva, Nicoleta C., Thrush, Philip T., Monge, Michael, Joong, Anna, Magnetta, Defne A.

“…Background The relationship between histopathologic and molecular (“MMDx”®) assessments of endomyocardial biopsy (EMB) and serum donor‐derived cell‐free DNA…”
Get full text

Clinical approach to acute cellular rejection from the pediatric heart transplant society by Bansal, Neha, Everitt, Melanie D., Nandi, Deipanjan, Spinner, Joseph, Conway, Jennifer, Magnetta, Defne A., Profita, Elizabeth L., Townsend, Madeleine, Alejos, Juan Carlos, Deshpande, Shriprasad R.

“…Background Early detection of cardiac allograft rejection is crucial for post‐transplant graft survival. Despite the progress made in immunosuppression…”
Get full text

Worsening racial disparity in waitlist mortality for pediatric heart transplant candidates since the 2016 Pediatric Heart Allocation Policy revision by Wright, Lydia K., Gajarski, Robert J., Phelps, Christina, Hoffman, Timothy M., Lytrivi, Irene D., Magnetta, Defne A., Shaw, Fawwaz R., Thompson, Consuela, Weisert, Molly, Nandi, Deipanjan

“…Background The US Pediatric Heart Allocation Policy (PHAP) was revised in March 2016, with the goal of reducing waitlist mortality. We evaluated the hypothesis…”
Get full text

Paroxysmal complete atrioventricular block in pediatric heart transplant recipients following cardiac catheterization: A case series by Magnetta, Defne A., Feingold, Brian, Beerman, Lee B., Blasiole, Brian, Arora, Gaurav

“…Late‐onset paroxysmal AVB has been described as a rare complication after HT and has been associated with AR or CAV. We describe 4 pediatric HT recipients who…”
Get full text

Cost-Effectiveness of Ventricular Assist Device Destination Therapy for Advanced Heart Failure in Duchenne Muscular Dystrophy by Magnetta, Defne A., Kang, JaHyun, Wearden, Peter D., Smith, Kenneth J., Feingold, Brian

“…Destination ventricular assist device therapy (DT-VAD) is well accepted in select adults with medically refractory heart failure (HF) who are not transplant…”
Get full text

Biventricular Assist Device Support for Intractable Arrhythmias From Histiocytoid Cardiomyopathy by Magnetta, Defne A., Reichhold, Allison, Thrush, Philip T., Monge, Michael, Webster, Gregory, Joong, Anna

“…Histiocytoid cardiomyopathy (HICMP) is a rare mitochondrial cardiomyopathy associated with recurrent life-threatening arrhythmias and variable degrees of…”
Get full text

Abstract 16610: Waitlist Characteristics and Outcomes Following the 2016 Revision of US Pediatric Heart Allocation Policy by Magnetta, Defne A, Godown, Justin, West, Shawn, Zinn, Matthew, Miller, Susan, Feingold, Brian

“…BackgroundUS pediatric heart allocation was revised in March 2016 to more appropriately categorize candidates with the most urgent need for heart…”
Get full text

Paroxysmal complete atrioventricular block in pediatric heart transplant recipients following cardiac catheterization: A case series by Magnetta, Defne A, Feingold, Brian, Beerman, Lee B, Blasiole, Brian, Arora, Gaurav

“…Late-onset paroxysmal AVB has been described as a rare complication after HT and has been associated with AR or CAV. We describe 4 pediatric HT recipients who…”
Get full text